AlzeCure Pharma AB (publ) (STO:ALZCUR)

Market Cap	455.06M +109.5%
Revenue (ttm)	n/a
Net Income	-59.22M
EPS	-0.55
Shares Out	114.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,731,064
Open	4.750
Previous Close	5.140
Day's Range	3.840 - 4.750
52-Week Range	1.300 - 6.500
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857 and ACD680 that...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALZCUR